Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Recombinant or Synthetic Nucleic Acid Molecules Registration

All research involving the use or manipulation of recombinant or synthetic nucleic acid molecules must be registered with the Biosafety Office in order to maintain compliance with institutional and federal regulations.
The Recombinant or Synthetic Nucleic Acid Molecules Registration form is available online at this link.

Once registered, experiments considered "exempt" as defined within the NIH Guidelines may be initiated upon notification from this office. Under normal circumstances the investigator can expect notification within a few days of submission.

All "non-exempt" research must be reviewed by the Institutional Biosafety Committee (IBC). Experiments requiring IBC review may not be initiated until a formal letter of approval is received by the investigator. IBC meetings occur monthly to bi-monthly depending on the volume of submissions under consideration.

>Back to Top

 
Health, Safety, and Environment News and Announcements

ALERTS RSSRSS

Occupational Health - The 2014–2015 Flu Season Is Winding Down (4/16/2015)

Updated Policy - HSE501 - Bloodborne Pathogen Exposure Control Plan (4/3/2015)

New Guidance - HSE G11: Guidance for Corrective Actions and Progressive Response for Ongoing or Repeat Laboratory Safety Violations (2/3/2015)

NEWS PodcastsRSS

DOT Training- Shipping Ebola Contaminated Waste (11/21/14)

HSE policies have been moved to the Hopkins Policies Online (HPO) website (7/8/14)

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.